Epigenetic silencing of miR-200c in breast cancer is associated with aggressiveness and is modulated by ZEB1-Reference-Cited by-同舟云学术

Epigenetic silencing of miR-200c in breast cancer is associated with aggressiveness and is modulated by ZEB1

Published:2016-11-01 Issue:2 Volume:56 Page:147-158
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosomes Cancer

Author:

Damiano Valentina¹,Brisotto Giulia¹,Borgna Silvia¹,di Gennaro Alessandra¹,Armellin Michela¹,Perin Tiziana²,Guardascione Michela¹³,Maestro Roberta¹,Santarosa Manuela¹^ORCID

Affiliation:

1. Functional Onco-Genomics and Genetics; CRO Aviano National Cancer Institute; via F. Gallini 2 Aviano PN 33081 Italy

2. Pathology; CRO Aviano National Cancer Institute; via F. Gallini 2 Aviano PN 33081 Italy

3. Medical Oncology Department, Gastrointestinal Unit; CRO Aviano National Cancer Institute; via F. Gallini 2 Aviano PN 33081 Italy

Funder

The Italian Ministry of Health (Ricerca Finalizzata)

Italian Association for Cancer Research

Associazione Via di Natale; Fondazione CRO Aviano Onlus

Fondazione Umberto Veronesi

Publisher

Wiley

Subject

Cancer Research,Genetics

Reference47 articles.

1. Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer;Aghdassi;Gut,2012

2. Epigenetic control of type 2 and 3 deiodinases in myogenesis: Role of Lysine-specific Demethylase enzyme and FoxO3;Ambrosio;Nucleic Acids Res,2013

3. Induction of EMT by Twist Proteins as a Collateral Effect of Tumor-Promoting Inactivation of Premature Senescence;Ansieau;Cancer Cell,2008

4. Involvement of members of the cadherin superfamily in cancer;Berx;Cold Spring Harbor Perspectives in Biology,2009

5. Mesenchymal traits are selected along with stem features in breast cancer cells grown as mammospheres;Borgna;Cell Cycle,2012

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and Translational Opportunities of Nanocarriers Containing RNAi for the Management of Triple‐Negative Breast Cancer;Advanced Therapeutics;2024-03-25

2. Deregulated MicroRNAs involved in P53 Signaling Pathway in Breast Cancer with Focus on Triple-negative Breast Cancer;Current Molecular Pharmacology;2023-11-03

3. miRNAs in the prognosis of triple-negative breast cancer: A review;Life Sciences;2023-11

4. MiR-183-5p promotes renal cell carcinoma metastasis by targeting TET1;International Journal of Immunopathology and Pharmacology;2023-08-16

5. Epigenetics of Breast Cancer;Genetics and Epigenetics of Breast Cancer;2023